Case report of a laryngeal squamous cell carcinoma treated with artesunate
Author(s) -
Narenda Singh,
K. Verma
Publication year - 2002
Publication title -
archive of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.104
H-Index - 13
eISSN - 1450-9520
pISSN - 0354-7310
DOI - 10.2298/aoo0204279s
Subject(s) - artesunate , artemisinin , medicine , cancer , drug , oncology , basal cell , pharmacology , malaria , pathology , plasmodium falciparum
This present report describes the treatment of a laryngeal squamous cell carcinoma patient with the water-soluble artemisinin analog, artesunate Artemisinin is a novel anti-cancer drug with demonstrated results in killing cancer cells. Artesunate injections and tablets were administered to the patient over a period of nine months. The tumor was significantly reduced (by 70%) after two months of treatment. Overall, the artesunate treatment of the patient was beneficial in prolonging and improving the quality of life Artemisinin and its analogs offer promise for cancer therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom